Literature DB >> 23201428

Neurodevelopmental and cognitive behavior of glutaryl-CoA dehydrogenase deficient knockout mice.

Estela Natacha Brandt Busanello1, Letícia Pettenuzzo, Paulo Henrique Botton, Pablo Pandolfo, Diogo Onofre Gomes de Souza, Michael Woontner, Stephen Goodman, David Koeller, Moacir Wajner.   

Abstract

AIMS: The establishment of a genetic knockout murine model of glutaric acidemia type I (GAI) with complete loss of glutaryl-CoA dehydrogenase (GCDH) activity has been used to investigate the pathological mechanisms underlying neurological symptoms in this disorder. However, very little has been reported on the neurobehavior of GCDH deficient mice (Gcdh(-/-)). MAIN
METHODS: In the present study we evaluated physical (body and weight gain) and neuromotor development (appearance of coat, upper incisor eruption, eye-opening day, motor coordination, muscular strength and climbing), as well as cognitive behavior (inhibitory avoidance) in Gcdh(-/-), as compared to wild type (WT) mice. KEY
FINDINGS: We found that Gcdh(-/-) mice did not differ in body and weight gain, appearance of coat, upper incisor eruption, motor coordination and muscular strength, but had a significant delayed eye opening, implying a mild impairment of neurodevelopment in these animals. Furthermore, the climbing behavior was significantly higher in Gcdh(-/-) as compared to WT mice, suggesting an altered dopaminergic function. Finally, Gcdh(-/-) mice presented a deficit of short- and long-term memories in the inhibitory avoidance task. SIGNIFICANCE: Although it is difficult to extrapolate the present findings to the human condition, our present data are particularly interesting in view of the psychomotor/mental delay that occurs in a significant number of GAI patients with no previous history of acute encephalopathy with striatum destruction. Strict and early treatment possibly associated with novel therapies seems therefore important to prevent learning/memory disabilities in GAI patients.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23201428     DOI: 10.1016/j.lfs.2012.11.013

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

1.  Induction of Neuroinflammatory Response and Histopathological Alterations Caused by Quinolinic Acid Administration in the Striatum of Glutaryl-CoA Dehydrogenase Deficient Mice.

Authors:  Alexandre Umpierrez Amaral; Bianca Seminotti; Janaína Camacho da Silva; Francine Hehn de Oliveira; Rafael Teixeira Ribeiro; Carmen Regla Vargas; Guilhian Leipnitz; Abel Santamaría; Diogo Onofre Souza; Moacir Wajner
Journal:  Neurotox Res       Date:  2017-12-12       Impact factor: 3.911

2.  Neurodevelopmental profiles of children with glutaric aciduria type I diagnosed by newborn screening: a follow-up case series.

Authors:  Amy Brown; Louise Crowe; Miriam H Beauchamp; Vicki Anderson; Avihu Boneh
Journal:  JIMD Rep       Date:  2014-12-11

3.  Glutaric acid-mediated apoptosis in primary striatal neurons.

Authors:  Fengyan Tian; Xi Fu; Jinzhi Gao; Yanqin Ying; Ling Hou; Yan Liang; Qin Ning; Xiaoping Luo
Journal:  Biomed Res Int       Date:  2014-05-12       Impact factor: 3.411

4.  Genetic variation and cognitive dysfunction in opioid-treated patients with cancer.

Authors:  Geana Paula Kurita; Ola Ekholm; Stein Kaasa; Pål Klepstad; Frank Skorpen; Per Sjøgren
Journal:  Brain Behav       Date:  2016-05-03       Impact factor: 2.708

5.  A cross-sectional controlled developmental study of neuropsychological functions in patients with glutaric aciduria type I.

Authors:  Nikolas Boy; Jana Heringer; Gisela Haege; Esther M Glahn; Georg F Hoffmann; Sven F Garbade; Stefan Kölker; Peter Burgard
Journal:  Orphanet J Rare Dis       Date:  2015-12-22       Impact factor: 4.123

6.  Neurotoxic effects of trans-glutaconic acid in rats.

Authors:  Patrícia F Schuck; Estela N B Busanello; Anelise M Tonin; Carolina M Viegas; Gustavo C Ferreira
Journal:  Oxid Med Cell Longev       Date:  2013-03-27       Impact factor: 6.543

7.  The biochemical subtype is a predictor for cognitive function in glutaric aciduria type 1: a national prospective follow-up study.

Authors:  E M Charlotte Märtner; Eva Thimm; Philipp Guder; Katharina A Schiergens; Frank Rutsch; Sylvia Roloff; Iris Marquardt; Anibh M Das; Peter Freisinger; Sarah C Grünert; Johannes Krämer; Matthias R Baumgartner; Skadi Beblo; Claudia Haase; Andrea Dieckmann; Martin Lindner; Andrea Näke; Georg F Hoffmann; Chris Mühlhausen; Magdalena Walter; Sven F Garbade; Esther M Maier; Stefan Kölker; Nikolas Boy
Journal:  Sci Rep       Date:  2021-09-29       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.